Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2000
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach ; volume:26 ; number:1 ; day:21 ; month:12 ; year:2021 ; pages:105-116 ; date:1.2022
Molecular diagnosis & therapy ; 26, Heft 1 (21.12.2021), 105-116, 1.2022
- Creator
-
Wojtaszewska, Marzena
Stępień, Rafał
Woźna, Alicja
Piernik, Maciej
Sztromwasser, Pawel
Dąbrowski, Maciej
Gniot, Michał
Szymański, Sławomir
Socha, Maciej
Kasprzak, Piotr
Matkowski, Rafał
Zawadzki, Paweł
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-021-00571-1
- URN
-
urn:nbn:de:101:1-2022043020013882613969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wojtaszewska, Marzena
- Stępień, Rafał
- Woźna, Alicja
- Piernik, Maciej
- Sztromwasser, Pawel
- Dąbrowski, Maciej
- Gniot, Michał
- Szymański, Sławomir
- Socha, Maciej
- Kasprzak, Piotr
- Matkowski, Rafał
- Zawadzki, Paweł
- SpringerLink (Online service)
Other Objects (12)
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Pinning down ploidy in paleopolyploid plants
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Classification of human cancers based on DNA copy number amplification modeling
The hybrid number of a ploidy profile
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Pinning down ploidy in paleopolyploid plants
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Classification of human cancers based on DNA copy number amplification modeling
The hybrid number of a ploidy profile
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Pinning down ploidy in paleopolyploid plants
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Classification of human cancers based on DNA copy number amplification modeling
The hybrid number of a ploidy profile